Minimum Lot Size
Issue Open Date
Issue Close Date
The company API holding is India’s largest digital healthcare platform. The firm operates an integrated, end-to-end business that aims to provide solutions for the healthcare needs of consumers across the following critical stages, providing digital tools and information on illness and wellness, offering teleconsultation, offering diagnostics and radiology tests, and delivering treatment protocols including products and devices. The firm differentiates itself by its custom-built proprietary technology, unified data platforms, supply chain capabilities, and deep understanding of the dynamic interplay between the various sub-segments of India’s healthcare market.
Firms' businesses have a presence across the country with last-mile capabilities to deliver in over 18,587 pin codes (for June 2021) via the PharmEasy marketplace, allowing us the ability to provide access affordable to the common man. The firm's platforms have scaled across urban, semi-urban, and rural India, with an ability to serve people across income groups and geographies.
|S.No.||1 - Company||2 - Directors||3 - Promoters|
|Entity Name||By the Company||Against the Company||By the Director||Against the Director||By the Promoter||Against the Promoter|
|Material civil cases||-||3||-||1||-||-|
|Income Statement(in Milllions)||Jue'2021||March'2021||March'202|
|Gross Operating Income||12,072.60||23,606.62||7,374.48|
|Cost of Employee & Inventory||1,658.39||2,702.94||1,371.90|
|Profit Before Tax and Exceptional items||-3,197.57||-6,202.66||-3,469.56|
|Profit After Tax||-3,138.91||-6,413.36||-3,352.79|
Our company does not have an identifiable promoter
• No listed Peer
Net proceeds from the fresh issue worth Rs6,250 cr will be utilized for:- • Repayment or pre-payment, in full or in part, of all or certain borrowings availed by our Company • Funding organic growth initiatives • Pursuing inorganic growth through acquisitions and other strategic initiatives • General corporate purposes